These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
874 related items for PubMed ID: 17489345
21. Comparative effects of levosimendan, OR-1896, OR-1855, dobutamine, and milrinone on vascular resistance, indexes of cardiac function, and O2 consumption in dogs. Banfor PN, Preusser LC, Campbell TJ, Marsh KC, Polakowski JS, Reinhart GA, Cox BF, Fryer RM. Am J Physiol Heart Circ Physiol; 2008 Jan; 294(1):H238-48. PubMed ID: 17982006 [Abstract] [Full Text] [Related]
22. Use of Levosimendan in Postoperative Setting After Surgical Repair of Congenital Heart Disease in Children. Amiet V, Perez MH, Longchamp D, Boulos Ksontini T, Natterer J, Plaza Wuthrich S, Cotting J, Di Bernardo S. Pediatr Cardiol; 2018 Jan; 39(1):19-25. PubMed ID: 28884218 [Abstract] [Full Text] [Related]
23. Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome. Uhlig K, Efremov L, Tongers J, Frantz S, Mikolajczyk R, Sedding D, Schumann J. Cochrane Database Syst Rev; 2020 Nov 05; 11(11):CD009669. PubMed ID: 33152122 [Abstract] [Full Text] [Related]
24. Intravenous levosimendan vs. dobutamine in acute decompensated heart failure patients on beta-blockers. Bergh CH, Andersson B, Dahlström U, Forfang K, Kivikko M, Sarapohja T, Ullman B, Wikström G. Eur J Heart Fail; 2010 Apr 05; 12(4):404-10. PubMed ID: 20335355 [Abstract] [Full Text] [Related]
25. Levosimendan improves postresuscitation outcomes in a rat model of CPR. Huang L, Weil MH, Sun S, Cammarata G, Cao L, Tang W. J Lab Clin Med; 2005 Nov 05; 146(5):256-61. PubMed ID: 16242524 [Abstract] [Full Text] [Related]
26. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery. Schroth M, Plank C, Meissner U, Eberle KP, Weyand M, Cesnjevar R, Dötsch J, Rascher W. Pediatrics; 2006 Jul 05; 118(1):e76-84. PubMed ID: 16751617 [Abstract] [Full Text] [Related]
30. [Superiority of levosimendan to dobutamine in postoperative low cardiac output syndrome: is it due to previous beta-blocker treatment?]. Homs S, González-Costello J. Rev Esp Cardiol; 2008 Nov 05; 61(11):1225; author reply 1225-6. PubMed ID: 19000504 [No Abstract] [Full Text] [Related]
32. [Intensive care for newborns and babies of the first year of life with acute heart failure after cardiosurgical interventions]. Lobacheva GV, Khar'kin AV, Manerova AF, Dzhobava ER. Anesteziol Reanimatol; 2010 Nov 05; (5):23-7. PubMed ID: 21400728 [Abstract] [Full Text] [Related]
35. Comparison of Levosimendan versus Dobutamine in Patients with Moderate to Severe Left Ventricular Dysfunction Undergoing Off-pump Coronary Artery Bypass Grafting: A Randomized Prospective Study. Kandasamy A, Simon HA, Murthy P, Annadurai M, Ali MM, Ramanathan G. Ann Card Anaesth; 2017 Nov 05; 20(2):200-206. PubMed ID: 28393781 [Abstract] [Full Text] [Related]
37. Inotropic agents and vasodilator strategies for acute myocardial infarction complicated by cardiogenic shock or low cardiac output syndrome. Unverzagt S, Wachsmuth L, Hirsch K, Thiele H, Buerke M, Haerting J, Werdan K, Prondzinsky R. Cochrane Database Syst Rev; 2014 Jan 02; (1):CD009669. PubMed ID: 24385385 [Abstract] [Full Text] [Related]
38. A comparison of hemodynamic effects of levosimendan and dobutamine in patients undergoing mitral valve repair / replacement for severe mitral stenosis. Gandham R, Syamasundar A, Ravulapalli H, Karthekeyan RB, Vakamudi M, Kodalli R, Nandipati S. Ann Card Anaesth; 2013 Jan 02; 16(1):11-5. PubMed ID: 23287080 [Abstract] [Full Text] [Related]
40. The effects of Levosimendan on global haemodynamics in patients with cardiogenic shock. Rokyta R, Pechman V. Neuro Endocrinol Lett; 2006 Jan 02; 27(1-2):121-7. PubMed ID: 16648778 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]